Investigation Of The Diabetes Drug Called Actos

[Northerner]

The US Drug Watchdog wants to hear from any user of the diabetes drug called Actos, who developed bladder cancer. According to the AP, "The FDA has issued a warning that Actos may be linked to an increased risk of bladder cancer. Meanwhile, both Germany and France have suspended sales of Actos. The Actos suspension is effective July 11, 2011. Actos (pioglitazone), along with another diabetes drug made by Takeda Pharmaceutical, Competact, came under fire in Europe after a study revealed an increased risk for bladder cancer among diabetes patients who were taking the medication." The US Drug Watchdog says, "We want to hear from any user of the diabetes medication called Actos, if they have developed bladder cancer.

http://www.sfgate.com/cgi-bin/article.cgi?f=/g/a/2011/11/21/prweb8981198.DTL

From the UK though:

http://londondiabetes.nhs.uk/NewsEvents/NewsArticles/2011/UpdateonPioglitazone.aspx